ENHANCING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY SERVICES AND RAS ASSAYS

while in the fast evolving discipline of oncology investigate, exact and effective mutation screening is crucial for creating qualified therapies. The KRAS companies System plays a pivotal part During this landscape by supplying extensive answers for KRAS mutation profiling and analysis. KRAS mutations, present in around 95% of RAS-similar oncogeni